14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Jun 07, 2019 $39.11 $39.84 $38.76 $39.68 317 224
Jun 06, 2019 $40.22 $40.84 $38.64 $38.75 315 209
Jun 05, 2019 $41.25 $41.25 $40.35 $40.37 191 952
Jun 04, 2019 $40.09 $41.10 $39.53 $41.04 339 588
Jun 03, 2019 $39.91 $40.07 $39.24 $39.69 313 394
May 31, 2019 $40.39 $40.92 $39.83 $39.89 210 204
May 30, 2019 $41.63 $41.83 $40.38 $40.69 206 149
May 29, 2019 $41.61 $41.90 $40.87 $41.33 234 428
May 28, 2019 $42.14 $42.45 $41.83 $42.04 238 221
May 24, 2019 $41.92 $42.64 $41.60 $42.06 218 995
May 23, 2019 $42.90 $42.90 $41.28 $41.57 464 547
May 22, 2019 $42.75 $43.36 $41.74 $43.25 270 661
May 21, 2019 $41.28 $43.00 $41.19 $42.90 268 593
May 20, 2019 $41.37 $41.76 $40.91 $41.01 276 592
May 17, 2019 $41.49 $42.64 $41.49 $41.76 214 599
May 16, 2019 $42.31 $43.10 $41.67 $41.92 263 863
May 15, 2019 $41.90 $42.31 $41.56 $42.11 256 756
May 14, 2019 $40.96 $42.24 $40.44 $42.04 285 976
May 13, 2019 $40.15 $41.20 $40.15 $40.65 566 045
May 10, 2019 $40.77 $41.77 $40.22 $41.48 309 602
May 09, 2019 $40.75 $41.90 $40.38 $41.51 238 171
May 08, 2019 $40.39 $41.88 $39.89 $41.04 199 934
May 07, 2019 $41.38 $41.83 $39.88 $40.42 233 175
May 06, 2019 $40.50 $41.94 $40.26 $41.77 202 117
May 03, 2019 $39.50 $41.51 $39.50 $41.49 273 316
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT